Danish healthcare region uses remote patient monitoring tool
Copenhagen, Denmark – 23 February 2016. Monsenso, a Copenhagen-based technology company, announced today that the Zealand Healthcare Region in Denmark will use the Monsenso mHealth solution for remote patient monitoring of patients with Borderline Personality Disorder (BPD).
The objective of the pilot study is to identify and track the triggers and early warning signs of patients with borderline, as well as to gather clinical evidence with the Monsenso mHealth solution.
The pilot study will be done in collaboration with the Produktion, Forskning and Innovation Centre of the Zealand Healthcare Region in Denmark. This branch focuses on identifying pioneering solutions that have the potential to improve the productivity of hospitals and the quality of life of its patients.
Thomas Lethenborg, CEO at Monsenso ApS, said that the Zealand Healthcare Region will conduct a 20-week pilot study of 30 patients starting in March.
“The Innovation Centre of the Zealand Healthcare Region in Denmark aims to offer its patients high-quality treatment with the latest technology available. With the implementation of the Monsenso mHealth solution, clinicians will be able to access a patient’s historical aggregated data, which will help them offer a better treatment based on evidence,” said Mr Lethenborg.
Jesper Lackman, Project Manager at The Produktion, Forskning and Innovation Centre, said the pilot study would allow them to investigate the benefits of the mHealth solution to improve patient engagement.
“The Produktion, Forskning and Innovation Centre has a strong commitment towards providing patient-centred care. We are continuously looking to improve our patients’ experience and this technology will help us learn more about our patients and their behavioural patterns. Our aim is to use this technology to support the treatment we currently provide to our patients,” said Mr Lackman.
For additional information contact:
Marketing and Communications Manager
+45 81 71 7713
PFI – Production, Science & Innovation
+45 8171 2900
You can download this article as PDF in English